CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 51 filers reported holding CATALYST BIOSCIENCES INC in Q2 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $90,000 | +11.1% | 17,937 | +39.9% | 0.00% | – |
| Q4 2020 | $81,000 | +42.1% | 12,821 | -2.8% | 0.00% | – |
| Q3 2020 | $57,000 | -9.5% | 13,189 | +23.7% | 0.00% | – |
| Q2 2020 | $63,000 | +3.3% | 10,660 | +40.7% | 0.00% | – |
| Q1 2019 | $61,000 | -1.6% | 7,578 | -3.1% | 0.00% | – |
| Q4 2018 | $62,000 | -27.1% | 7,823 | -0.8% | 0.00% | – |
| Q3 2018 | $85,000 | -5.6% | 7,884 | +1.8% | 0.00% | – |
| Q2 2018 | $90,000 | – | 7,741 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 202,281 | $2,759,000 | 1.56% |
| ACUTA CAPITAL PARTNERS, LLC | 450,000 | $6,138,000 | 1.16% |
| NEXTHERA CAPITAL LP | 311,175 | $4,244,000 | 0.78% |
| Avoro Capital Advisors LLC | 400,000 | $5,456,000 | 0.35% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $818,000 | 0.34% |
| B. Riley Wealth Advisors, Inc. | 62,500 | $853,000 | 0.12% |
| Kalos Management, Inc. | 12,100 | $222,000 | 0.10% |
| J. Goldman & Co LP | 124,500 | $1,698,000 | 0.09% |
| ARDSLEY ADVISORY PARTNERS LP | 15,000 | $205,000 | 0.02% |
| DRW Securities, LLC | 12,000 | $164,000 | 0.02% |